Biomarin Pharmaceuticals (BMRN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2002 | 03-2002 | 12-2001 | 09-2001 | 06-2001 | |
| Sales | 0 | 3,792 | 2,709 | 3,079 | 3,012 |
| Gross Profit | N/A | 3,792 | 2,709 | 3,079 | 3,012 |
| Operating Expenses | 9,552 | 28,367 | 4,067 | 12,379 | 13,042 |
| Operating Income | -9,552 | -24,575 | 2,709 | -9,300 | -10,030 |
| Interest Expense | 161 | 91 | 6 | 8 | 1 |
| Other Income | -4,860 | -1,918 | 6 | -1,334 | -1,300 |
| Pre-tax Income | -14,573 | -26,584 | 2,709 | -10,642 | -11,331 |
| Net Income Continuous | -14,573 | -26,584 | 2,709 | -10,642 | -11,331 |
| Net Income Discontinuous | 162 | -19 | -8,550 | -373 | -638 |
| Net Income | $-14,411 | $-26,603 | $2,709 | $-11,015 | $-11,969 |
| EPS Basic Total Ops | -0.27 | -0.51 | -0.83 | -0.26 | -0.30 |
| EPS Basic Continuous Ops | -0.27 | -0.51 | -0.63 | -0.25 | -0.28 |
| EPS Basic Discontinuous Ops | 0.00 | 0.00 | -0.20 | -0.01 | -0.02 |
| EPS Diluted Total Ops | -0.27 | -0.51 | -0.83 | -0.26 | -0.30 |
| EPS Diluted Continuous Ops | -0.27 | -0.51 | -0.63 | -0.25 | -0.28 |
| EPS Diluted Discontinuous Ops | 0.00 | 0.00 | -0.20 | -0.01 | -0.02 |
| EBITDA(a) | $-7,374 | $-22,514 | $1,192 | $-7,708 | $-8,539 |